AIDS

1. SOULIE C, Balde A, Fofana D, Charpentier C, et al
   No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
   AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

2. MELNYCHUK S, Green K, Ejeckam C, Adesina A, et al
   HIV drug resistance among key populations in Nigeria: Insights from the 2020 integrated biological and behavioural surveillance survey.
   J Acquir Immune Defic Syndr. 2025 Sep 11. doi: 10.1097/QAI.0000000000003763.
   

   >> Share

   
   

   
   PLoS Med

3. MUGWANY KK, Saina M, Mugo NR, MaWhinney S, et al
   Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study.
   PLoS Med. 2025;22:e1004732.
   

   >> Share

   
   

   
   PLoS Pathog

4. LI G, Ma J, Yu H, Tsahouridis O, et al
   CD24-Fc resolves inflammation and enhances anti-HIV CD8 T cells with polyfunctionality during HIV-1 infection under ART.
   PLoS Pathog. 2025;21:e1012826.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share